Karaboğa Arslan, A. K. Et Al. 2022. Synergistic Growth Inhibitory Effects of Eryngium kotschyi Extracts with Conventional Cytotoxic Agents: Cisplatin and Doxorubicin Against Human Endometrium Cancer Cells. Current Pharmaceutical Biotechnology , vol.23, no.5 , 740-748.

Karaboğa Arslan, A. K., Pasayeva, L., Esen, M. A., & Tugay, O., (2022). Synergistic Growth Inhibitory Effects of Eryngium kotschyi Extracts with Conventional Cytotoxic Agents: Cisplatin and Doxorubicin Against Human Endometrium Cancer Cells. Current Pharmaceutical Biotechnology , vol.23, no.5, 740-748.

Karaboğa Arslan, AYŞE Et Al. "Synergistic Growth Inhibitory Effects of Eryngium kotschyi Extracts with Conventional Cytotoxic Agents: Cisplatin and Doxorubicin Against Human Endometrium Cancer Cells," Current Pharmaceutical Biotechnology , vol.23, no.5, 740-748, 2022

Karaboğa Arslan, AYŞE K. Et Al. "Synergistic Growth Inhibitory Effects of Eryngium kotschyi Extracts with Conventional Cytotoxic Agents: Cisplatin and Doxorubicin Against Human Endometrium Cancer Cells." Current Pharmaceutical Biotechnology , vol.23, no.5, pp.740-748, 2022

Karaboğa Arslan, A. K. Et Al. (2022) . "Synergistic Growth Inhibitory Effects of Eryngium kotschyi Extracts with Conventional Cytotoxic Agents: Cisplatin and Doxorubicin Against Human Endometrium Cancer Cells." Current Pharmaceutical Biotechnology , vol.23, no.5, pp.740-748.

@article{article, author={AYŞE KÜBRA KARABOĞA ARSLAN Et Al. }, title={Synergistic Growth Inhibitory Effects of Eryngium kotschyi Extracts with Conventional Cytotoxic Agents: Cisplatin and Doxorubicin Against Human Endometrium Cancer Cells}, journal={Current Pharmaceutical Biotechnology}, year=2022, pages={740-748} }